Resultats de la cerca - Richard M. Sherry

Refinar resultats
  1. 1
    Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma

    Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma per Liqiang Xi, Trinh H. Pham, Eden C. Payabyab, Richard M. Sherry, Steven A. Rosenberg, Mark Raffeld

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy

    Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy per Jenny J. Hong, Steven A. Rosenberg, Mark E. Dudley, James Chih‐Hsin Yang, Donald E. White, John A. Butman, Richard M. Sherry

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Determination of the Elimination Half-Life of Fibroblast Growth Factor-23

    Determination of the Elimination Half-Life of Fibroblast Growth Factor-23 per Azarmindokht Khosravi, Carolee M. Cutler, Marilyn H Kelly, Richard Chang, Richard E. Royal, Richard M. Sherry, Felasfa M. Wodajo, Neal S. Fedarko, Michael T. Collins

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

    Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy per Kathryn M. Cappell, Richard M. Sherry, James C. Yang, Stephanie L. Goff, Danielle Vanasse, Lori McIntyre, Steven A. Rosenberg, James N. Kochenderfer

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma

    CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma per Peter A. Prieto, James Chih‐Hsin Yang, Richard M. Sherry, Marybeth S. Hughes, Udai S. Kammula, Donald E. White, Catherine Lévy, Steven A. Rosenberg, Giao Q. Phan

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

    A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer per James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Seth M. Steinberg, Helen X. Chen, Steven A. Rosenberg

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

    Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma per Richard E. Royal, Catherine Lévy, Keli Turner, Aarti Mathur, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Israel Lowy, Steven A. Rosenberg

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma

    High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma per Jacob A. Klapper, Stephanie G. Downey, Franz O. Smith, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Richard E. Royal, Seth M. Steinberg, Steven A. Rosenberg

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL

    Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL per Stephanie L. Goff, Franz O. Smith, Jacob A. Klapper, Richard M. Sherry, John R. Wunderlich, Seth M. Steinberg, Donald White, Steven A. Rosenberg, Mark E. Dudley, James C. Yang

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy per James N. Kochenderfer, Robert Somerville, Tangying Lu, James C. Yang, Richard M. Sherry, Steven A. Feldman, Lori McIntyre, Adrian Bot, John M. Rossi, Norris Lam, Steven A. Rosenberg

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases

    Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases per Gautam U. Mehta, Parisa Malekzadeh, Thomas E. Shelton, Donald E. White, John A. Butman, James Chih‐Hsin Yang, Udai S. Kammula, Stephanie L. Goff, Steven A. Rosenberg, Richard M. Sherry

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

    Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with respo... per Barbara A. Pockaj, Richard M. Sherry, John P. Wei, John R. Yannelli, Charles S. Carter, Susan F. Leitman, Jorge A. Carasquillo, Seth M. Steinberg, Steven A. Rosenberg, James Chih‐Hsin Yang

    Publicat 1994
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer

    Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer per Joseph Blansfield, Kimberly E Beck, Khoi Tran, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Suzanne L. Topalian, Leah Haworth, Catherine Lévy, Steven A. Rosenberg, Richard M. Sherry

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

    Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans per Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study

    T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study per Stacey L. Doran, Sanja Stevanović, Sabina Adhikary, Jared J. Gartner, Li Jia, Mei Li M. Kwong, William C. Faquin, Stephen M. Hewitt, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Christian S. Hinrichs

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

    Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis per James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Richard M. Sherry, Suzanne L. Topalian, Kimberly B. Suri, Catherine Lévy, Tamika Allen, Sharon Mavroukakis, Israel Lowy, Donald E. White, Steven A. Rosenberg

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma

    Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma per Ajay V. Maker, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Marybeth S. Hughes, Michael Yellin, Leah Haworth, Catherine Lévy, Tamika Allen, Sharon Mavroukakis, Peter Attia, Steven A. Rosenberg

    Publicat 2006
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen

    Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen per Steven A. Rosenberg, James C. Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Nicholas P. Restifo, Leah Haworth, Claudia A. Seipp, Linda J. Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White

    Publicat 2003
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines

    Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines per Franz O. Smith, Stephanie G. Downey, Jacob A. Klapper, James C. Yang, Richard M. Sherry, Richard E. Royal, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Catherine Lévy, Donald E. White, Seth M. Steinberg, Steven A. Rosenberg

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

    Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study per Ajay V. Maker, Giao Q. Phan, Peter Attia, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Leah Haworth, Catherine Lévy, David E. Kleiner, Sharon Mavroukakis, Michael Yellin, Steven A. Rosenberg

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: